David Ebersman Net Worth

The estimated Net Worth of David A Ebersman is at least $137 Milione dollars as of 28 May 2014. Mr. Ebersman owns over 23,400 units of Castlight Health Inc stock worth over $672,462 and over the last 12 years he sold CSLT stock worth over $135,916,472. In addition, he makes $182,500 as Independent Director at Castlight Health Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Ebersman CSLT stock SEC Form 4 insiders trading

David has made over 36 trades of the Castlight Health Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 23,400 units of CSLT stock worth $1,488,708 on 28 May 2014.

The largest trade he's ever made was selling 911,700 units of Castlight Health Inc stock on 8 November 2013 worth over $42,631,092. On average, David trades about 41,453 units every 8 days since 2012. As of 28 May 2014 he still owns at least 328,030 units of Castlight Health Inc stock.

You can see the complete history of Mr. Ebersman stock trades at the bottom of the page.

David Ebersman biography

David A. Ebersman serves as Independent Director of the Company. Mr. Ebersman is currently CEO of Lyra Health, Inc., a company providing technology-enabled behavioral health care services. Previously, Mr. Ebersman served as the Chief Financial Officer of Facebook, Inc., from 2009 through 2014. Prior to joining Facebook, Mr. Ebersman served in various positions at Genentech, Inc., a biotechnology company, including as its Executive Vice President and Chief Financial Officer, Senior Vice President, Product Operations, and Vice President, Product Development. Prior to joining Genentech, Mr. Ebersman was a research analyst at Oppenheimer & Company, Inc., an investment company. Mr. Ebersman has been a member of the board of directors of SurveyMonkey, Inc. since June 2015. Mr. Ebersman holds an A.B. in International Relations and Economics from Brown University and was selected for a Henry Crown Fellowship in 2000. Mr. Ebersman brings to our Board of Directors over twenty years of business, operations, strategic planning and financial experience with leading companies, such as Genentech and Facebook.

What is the salary of David Ebersman?

As the Independent Director of Castlight Health Inc, the total compensation of David Ebersman at Castlight Health Inc is $182,500. There are 9 executives at Castlight Health Inc getting paid more, with Maeve O'Meara having the highest compensation of $4,640,140.

What's David Ebersman's mailing address?

David's mailing address filed with the SEC is C/O CASTLIGHT HEALTH, INC., 150 SPEAR STREET, SUITE 400, SAN FRANCISCO, CA, 94105.

Insiders trading at Castlight Health Inc

Over the last 11 years, insiders at Castlight Health Inc have traded over $4,364,752 worth of Castlight Health Inc stock and bought 4,058,729 units worth $25,270,820 . The most active insiders traders include Associates V Lpvenrock Part..., Bryan E Roberts e David A Ebersman. On average, Castlight Health Inc executives and independent directors trade stock every 16 days with the average trade being worth of $124,164. The most recent stock trade was executed by Maeve O'meara on 16 November 2021, trading 186,290 units of CSLT stock currently worth $381,895.

What does Castlight Health Inc do?

Castlight is on a mission to make it as easy as humanly possible for its users to navigate the healthcare system and live happier, healthier, more productive lives. Its health navigation platform connects hundreds of health vendors, benefits resources, and plan designs into one comprehensive health and wellbeing experience. The platform guides individuals-based on their unique profile-to the best resources available to them, whether they are healthy, chronically ill, or actively seeking medical care. Castlight transforms the employee benefit experience into a deeply personalized, yet simple, guided one, empowering better-informed patient decisions to unlock better healthcare outcomes and maximizing return on healthcare investments.

Complete history of Mr. Ebersman stock trades at Meta Platforms Inc, Ironwood Pharmaceuticals Inc, Castlight Health Inc e SVMK Inc

Castlight Health Inc executives and stock owners

Castlight Health Inc executives and other stock owners filed with the SEC include:

• Maeve O'Meara,
  Chief Executive Officer, Director
• William Bondurant,
  Chief Financial Officer
• Maeve O'Meara,
  CEO & Director
• Will Bondurant,
  Sr. VP & CFO
• Bryan Roberts,
  Independent Chairman of the Board, Co-Founder
• Judith Verhave,
  Independent Director
• Edward Park,
  Independent Director
• Michael Eberhard,
  Independent Director
• David Singer,
  Independent Director
• David Ebersman,
  Independent Director
• Kenny Van Zant,
  Independent Director
• Seth Cohen,
  Director
• Dr. Bryan Eisman Roberts,
  Independent Chairman & Co-Founder
• Eric Chan,
  Chief Accounting Officer
• Nita Sommers,
  Chief Growth Officer
• Dr. Dena Bravata M.S.,
  Chief Medical Officer
• Frank D. Jennings,
  Sr. VP & Chief Sales Officer
• Tamar Rudnick,
  Sr. VP of Marketing
• Matt Moran,
  Sr. VP of Corp. Devel.
• Alex Shvartsman,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Gary J. Fuges C.F.A., CFA,
  Head of Investor Relations
• M P Eric Chan,
  Chief Accounting Officer
• Mangini Siobhan Nolan,
  President
• Priya Jain,
  Corporate Controller & CAO
• Robert Derek Newell,
  President
• James P. Currier,
  Director
• Associates V Lpvenrock Part...,
  
• Jonathan Rende,
  Chief Research & Dev. Officer
• Giovanni M. Colella,
  CEO and Co-Founder
• John Mc Cracken,
  SVP, World Wide Sales
• Jennifer Chaloemtiarana,
  General Counsel
• Ed Park,
  Director
• John C Doyle,
  CFO, V.P. & Treasurer
• Neeraj Gupta,
  EVP, Engineering
• Investment Partners Xii L P...,
  10% owner
• Associates V Lpvenrock Part...,
  
• Randall J. Womack,
  COO and V.P.
• Naomi L Allen,
  10% owner
• Sudhir Steven Singh,
  Director
• Management Group X Llcus Ve...,
  
• Dena Bravata,
  Chief Med Ofcr/HeadofProducts
• Trust Ltd (The) As Trustee ...,
  10% owner
• Inc Athenahealth,
  10% owner
• Christopher P. Michel,
  Director
• Robert Kocher,
  Director
• Ann H Lamont,
  Director
• Ann Hoak Investment Partner...,
  
• Michele K. Law,
  Chief Revenue Officer
• Capital Ltdmaverick Capital...,
  
• Helen Kotchoubey,
  Chief Operating Officer